Gene targeting approach to selectively kill colon cancer cells, with hyperactive K-Ras pathway

Biomedicine and Pharmacotherapy

Volumn 59, Issue SUPPL. 2, 2005, Pages

  Dvory Sobol, H ^a,b   Kazanov, D ^a   Arber, N ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Colon cancer; K Ras; Responsive element

Indexed keywords

CASPASE 8; CYCLIC GMP DEPENDENT PROTEIN KINASE; K RAS PROTEIN; LUCIFERASE; PROTEIN BAX;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL KILLING; CELL TRANSFORMATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PLASMID VECTOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 8; CASPASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIC GMP; GENE TARGETING; GENE THERAPY; GENES, RAS; GENES, REPORTER; HUMANS; LUCIFERASES; PLASMIDS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 33644527626     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(05)80081-2     Document Type: Article

References (33)

1. Adjei A.A. Blocking oncogenic Ras signaling for cancer therapy J Natl Cancer Inst 93 2001 1062 1074
2. Alemany R., Ruan S., Kataoka M., Koch P.E., Mukhopadhyay T., and Cristiano R.J. Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells Cancer Gene Ther 3 1996 296 301
3. Aoyama A., and Klemenz R. Oncogene-mediated effects on cellular gene expression Crit Rev Oncog 4 1993 53 94
4. Arber N., Shapira I., Ratan J., Stern B., Hibshoosh H., and Moshkowitz M. Activation of c-K-ras mutations in human gastrointestinal tumors Gastroenterology 118 2000 1045 1050
5. Arber N., Sutter T., Miyake M., Kahn S.M., Venkatraj V.S., and Sobrino A. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes Oncogene 12 1996 1903 1908
6. Bortner D.M., Langer S.J., and Ostrowski M.C. Non-nuclear oncogenes and the regulation of gene expression in transformed cells Crit Rev Oncog 4 1993 137 160
7. Bos J.L., Fearon E.R., Hamilton S.R., Verlaan-de Vries M., van Boom J.H., van der Eb A.J., and Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers Nature 327 1987 293 297
8. Bos J.L. ras oncogenes in human cancer: a review Cancer Res 49 1989 4682 4689
9. Chambers A.F., and Tuck A.B. Ras-responsive genes and tumor metastasis Crit Rev Oncog 4 1993 95 114
10. Downward J. Cell cycle: routine role for ras Curr Biol 7 1997 258 260
11. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
12. Finco T.S., and Baldwin A.S. Jr Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1 J Biol Chem 268 1993 17676 17679
13. Galang C.K., Der C.J., and Hauser C.A. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites Oncogene 9 1994 2913 2921
14. Georges R.N., Mukhopadhyay T., Zhang Y., Yen N., and Roth J.A. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct Cancer Res 53 1993 1743 1746
15. Grady W.M., and Markowitz S.D. Genetic and epigenetic alterations in colon cancer Annu Rev Genom Hum Genet 3 2002 101 128
16. Gutman A., and Wasylyk B. Nuclear targets for transcription regulation by oncogenes Trends Genet 7 1991 49 54
17. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., and Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria Proc Natl Acad Sci USA 95 1998 4997 5002
18. Kashani-Sabet M., Funato T., Tone T., Jiao L., Wang W., and Yoshida E. Reversal of the malignant phenotype by an anti-ras ribozyme Antisense Res Dev 2 1992 3 15
19. Koizumi M., Kamiya H., and Ohtsuka E. Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene Gene 117 1992 179 184
20. Kornmann M., Danenberg K.D., Arber N., and Hans G. Beger, Peter V. Danenberg and Murray Korc inhibition of cyclin DI expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes Cancer Res 59 1999 3505 3511
21. Marshall C.J. ras effectors Curr Opin Cell Biol 8 1996 197 204
22. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., and Ni J. A novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817 827
23. Reddy M.A., Langer S.J., Colman M.S., and Ostrowski M.C. An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites Mol Endocrinol 6 1992 1051 1060
24. Saison-Behmoaras T., Tocque B., Rey I., Chassignol M., Thuong N.T., and Helene C. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation EMBO J 10 1991 1111 1118
25. Sassone-Corsi P., Der C.J., and Verma I.M. ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun Mol Cell Biol 9 1989 3174 3183
26. Sif S., Capobianco A.J., and Gilmore T.D. The v-Rel oncoprotein increases expression from Spl site-containing promoters in chicken embryo fibroblasts Oncogene 8 1993 2501 2509
27. Soh J.W., Mao Y., Liu L., Thompson W.J., Pamukcu R., and Weinstein I.B. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1 J Biol Chem 276 2001 16406 16410
28. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., and Yang X. Pro-caspase-3 is a major physiologic target of caspase-8 J Biol Chem 273 1998 27084 27090
29. Volpers C., and Kochanek S. Adenoviral vectors for gene transfer and therapy J Gene Med 6 Suppl 1 2004 5164 5171
30. Wasylyk C., Flores P., Gutman A., and Wasylyk B. PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes EMBO J 8 1989 3371 3378
31. Wasylyk C., Gutman A., Nicholson R., and Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins EMBO J 10 1991 1127 1134
32. Weinberg R.A. Racing to the beginning of the road 1996 New-York Harmony Books
33. Yang B.S., Hauser C.A., Henkel G., Colman M.S., Van Beveren C., and Stacey K.J. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Etsl and c-Ets2 Mol Cell Biol 16 1996 538 547